Skip to main content
SpringerLink
Log in

Dabigatran etexilate has favourable safety profile in children

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Brandao LR, et al. Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children. Blood : 5 Dec 2019. Available from: URL: http://doi.org/10.1182/blood.2019000998

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dabigatran etexilate has favourable safety profile in children. Reactions Weekly 1783, 11 (2019). https://doi.org/10.1007/s40278-019-72494-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-72494-2

Search

Navigation